[ad_1]
The preliminary evaluation report on the coronavac vaccine to be implemented in Turkey was announced. The preliminary evaluation report of the Phase 3 studies was reported to reveal that the vaccine was safe and effective at a rate of 91.25 percent. How effective is the vaccine known as the Chinese vaccine? Here are the details of the evaluation …
According to the news from Anadolu Agency,Developed by the company in Turkey continued sinovac coronavac out of the preliminary evaluation report on the Phase-3 study, the vaccine was safe and effective, reportedly revealed the rate of 91.25 percent.
Ministry of Health, in the fight against the coronavirus, reliability and
The effectiveness of a vaccine to ensure that its citizens move quickly to implement a story, Turkey, the coronavac sinovac vaccine produced by the Chinese company had participated in clinical trials.
The preliminary report on the phase 3 clinical trials, which began on September 14, revealed that the CoronaVac vaccine is effective and safe.
According to the report, 7,371 of 9,150 volunteers were included in the phase 3 studies. Of these, 4,759 (64.6 percent) participated in the vaccine arm and 2,612 (35.4 percent) participated in the vaccine arm. percent) in the placebo arm (empty vaccine).
10,828 doses were administered to a total of 7,371 volunteers.
In the framework of the study, two doses were administered to 3,457 volunteers.
The evaluations were conducted with a total of 1,322 people, 752 who received the CoronaVac vaccine and 570 volunteers who received placebo.
THE RELIABILITY OF THE VACCINE HAS BEEN ANALYZED
The preliminary report also included studies on the reliability of the vaccine.
Consequently, vaccine safety analyzes were conducted with data from 2,964 people,
593 of them had mild side effects such as fatigue and headache.
After the first dose of the vaccine, 4.7 percent of the volunteers had fatigue, 3.9 percent had headaches, and 1.9 percent had pain at the vaccine site.
While there are no changes in side effects after the second dose,
rates are 2.5 percent fatigue, 2.3 percent headache,
0.5 percent decreased in the form of pain in the area of the vaccine.
The studies, in which corona was detected in 29 of the volunteers, will continue until this number reaches 40.
